Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

14.6K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.6K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

1.1K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stromal peroxidasin drives early tumor growth in breast cancer.

iScience·2026
Same author

Medicinal food plants of Sabah (Eastern Malaysia): a source of potential natural products and nutraceuticals for the fight against cancer.

Pharmaceutical biology·2026
Same author

Regional Nasal Drug Deposition in Pediatric vs. Adult Models: In vitro Insights into User Technique and Breathing Patterns Sensitivity.

Pharmaceutical research·2026
Same author

Spt7 Deletion Reveals Vulnerabilities in <i>Cryptococcus neoformans</i> Stress Adaptation and Virulence.

Microorganisms·2026
Same author

Extracting Value from Marine and Microbial Natural Product Artifacts and Chemical Reactivity.

Marine drugs·2026
Same author

Rapid profiling of polymyxin B susceptibility in Gram-negative bacteria with a novel polymyxin-derived fluorescent probe.

Journal of advanced research·2026

Related Experiment Video

Updated: Feb 18, 2026

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.4K

Antimicrobial Octapeptin C4 Analogues Active against Cryptococcus Species.

Jessica L Chitty1,2, Mark S Butler2, Azzah Suboh2

  • 1Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland, Australia.

Antimicrobial Agents and Chemotherapy
|November 22, 2017
PubMed
Summary

Octapeptin C4 shows potent antifungal activity against Cryptococcus neoformans, a major cause of mortality in AIDS patients. This novel agent is effective against resistant strains, offering a promising new therapeutic option.

Keywords:
Cryptococcus neoformansantifungal agentslipopeptideoctapeptin

More Related Videos

Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

2.9K
Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
09:18

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

1.4K

Related Experiment Videos

Last Updated: Feb 18, 2026

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.4K
Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

2.9K
Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
09:18

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

1.4K

Area of Science:

  • Antimicrobial resistance
  • Mycology
  • Drug discovery

Background:

  • Antimicrobial resistance is a global health crisis, particularly impacting opportunistic fungal infections like Cryptococcus neoformans in immunocompromised individuals.
  • Cryptococcus neoformans is a significant cause of mortality, especially in regions with high HIV/AIDS prevalence, and exhibits increasing resistance to existing antifungal treatments.

Purpose of the Study:

  • To evaluate the antifungal potential of octapeptin C4, a cationic cyclic lipopeptide, against the fungal pathogen Cryptococcus neoformans.
  • To determine the minimum inhibitory concentration (MIC) of octapeptin C4 against various clinical isolates of Cryptococcus neoformans and compare its efficacy to current antifungal drugs.

Main Methods:

  • Minimum inhibitory concentration (MIC) assays were performed to assess the potency of octapeptin C4 against Cryptococcus neoformans.
  • Testing included clinical isolates of C. neoformans var. grubii, neoformans, and gattii, with comparisons made against fluconazole and amphotericin B.
  • Structure-activity relationship studies were conducted using synthetic octapeptin C4 derivatives.

Main Results:

  • Octapeptin C4 demonstrated potent and selective inhibition of Cryptococcus neoformans with MIC values ranging from 0.78 to 12.5 μg/ml across different varieties.
  • Its efficacy was comparable or superior to fluconazole and amphotericin B against clinical isolates.
  • The study identified lipophilic amino acid moieties as crucial for octapeptin C4's anticryptococcal activity.

Conclusions:

  • Octapeptin C4 exhibits significant potential as a novel therapeutic agent for treating Cryptococcus neoformans infections.
  • Its effectiveness against resistant strains highlights its value in addressing the growing challenge of antifungal resistance.
  • Further development of octapeptins could lead to new anticryptococcal drugs.